• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Out-patient, multi-modal behaviour therapy for obsessive-compulsive disorder.

作者信息

Hand I

机构信息

Universitätskrankenhaus Eppendorf, Psychiatrische und Nervenklinik, Hamburg, Germany.

出版信息

Br J Psychiatry Suppl. 1998(35):45-52.

PMID:9829026
Abstract

BACKGROUND

With regard to long-term outcome, behaviour therapy is the first choice treatment for obsessive-compulsive disorder (OCD), with or without concomitant selective serotonin reuptake inhibitor (SSRI) medication. Yet, results from research trials, usually restricted to exposure with response-preventions and other symptom-directed techniques, may not be generalisable to people with OCD in community health care services.

METHOD

For more than 20 years we have delivered out-patient behaviour therapy to unselected people with OCD from the community, including those with motivational and compliance problems. Prospective-retrospective follow-ups were carried out from 1-13 years after treatment.

RESULTS

This paper describes the applied multi-modal, strategic-systemic behaviour therapy, and our partially new model of OCD. Compliant patients achieved the usual success rate of 65-70%, but this drops to 50% if all patients treated are included in the analysis.

CONCLUSIONS

For major subgroups of OCD, behavior therapy is a very effective treatment modality. Exposure is essential, but additional ('causal') interventions are equally important in about half of the patients from unselected samples. Both behaviour therapy and drug-treatments need to be improved and predictive variables for outcome of either of them are urgently needed.

摘要

相似文献

1
Out-patient, multi-modal behaviour therapy for obsessive-compulsive disorder.
Br J Psychiatry Suppl. 1998(35):45-52.
2
[Ambulatory behavior therapy in obsessive-compulsive disorders].[强迫症的门诊行为疗法]
Fortschr Neurol Psychiatr. 1995 Jun;63 Suppl 1:12-8.
3
[Is it time for revision of the section on obsessive-compulsive disorder in the Guideline on Anxiety Disorders?].《焦虑症指南》中关于强迫症的章节是否需要修订?
Tijdschr Psychiatr. 2007;49(5):315-25.
4
D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.D-环丝氨酸不能增强强迫症的暴露反应预防疗法。
Int Clin Psychopharmacol. 2007 Jul;22(4):230-7. doi: 10.1097/YIC.0b013e32819f8480.
5
Behavior therapy for obsessive compulsive disorder.
Psychiatr Clin North Am. 1992 Dec;15(4):885-94.
6
How effective are cognitive and behavioral treatments for obsessive-compulsive disorder? A clinical significance analysis.认知行为疗法对强迫症的效果如何?一项临床意义分析。
Behav Res Ther. 2005 Dec;43(12):1543-58. doi: 10.1016/j.brat.2004.11.007.
7
Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.强迫症的动物模型:理解心理生物学和药理学的理论基础
Psychiatr Clin North Am. 2006 Jun;29(2):371-90. doi: 10.1016/j.psc.2006.02.007.
8
[Obsessive-compulsive disorders--inpatient behavior therapy].[强迫症——住院行为疗法]
Fortschr Neurol Psychiatr. 1995 Jun;63 Suppl 1:19-22.
9
Obsessive-compulsive disorder in children and adolescents.儿童和青少年强迫症
Br J Psychiatry Suppl. 1998(35):91-6.
10
[Prospective follow-up over a 12 month period of a cohort of 155 patients with obsessive-compulsive disorder: phase III National DRT-TOC Study].[155例强迫症患者队列的12个月前瞻性随访:国家DRT-TOC研究III期]
Encephale. 2000 Nov-Dec;26(6):73-83.

引用本文的文献

1
How to treat the untreated: effectiveness of a self-help metacognitive training program (myMCT) for obsessive-compulsive disorder.如何治疗未接受治疗的患者:一种针对强迫症的自助式元认知训练计划(myMCT)的有效性
Dialogues Clin Neurosci. 2010;12(2):209-20. doi: 10.31887/DCNS.2010.12.2/smoritz.
2
Obsessive-Compulsive Disorder and Tourette's Syndrome.强迫症与妥瑞氏症。
Curr Treat Options Neurol. 2000 Mar;2(2):125-140. doi: 10.1007/s11940-000-0014-1.